TransCode Therapeutics Reports 2022 Results; Provides Business Update

BOSTON, March 31, 2023 -- TransCode Therapeutics, Inc. , the RNA oncology company committed to defeating cancer using RNA therapeutics, today reported financial results for 2022 and recent business... | March 31, 2023

Related Keywords

Texas ,United States ,Boston ,Massachusetts ,Zdravka Medarova ,Michael Dudley ,Alan Freidman ,University Of Texas Md Anderson Cancer Center ,Exchange Commission ,Nasdaq ,Transcode Therapeutics Inc ,Transcode Co ,Code Therapeutics ,Chief Technology Officer ,Orphan Drug Designation ,Frank Slack ,Private Securities Litigation Reform Act ,Investigational New Drug ,Nasdaq Capital Market ,Annual Report ,Transcode Therapeutics ,Nc Stock Exchange ,News ,Information ,Press Release ,Arch ,023 ,Transcode ,The ,Na ,Ncology ,Company ,Ommitted ,O ,Defeating ,Dancer ,Sing ,Oday ,Eported ,Financial ,Results ,Or ,022 ,End ,Ecent Rnaz Us89357l1052 ,